Feladilimab
Product Specifications
CAS Number
2252518-85-5
Target
PD-1/PD-L1, COX
Related Pathways
Cell Cycle/Checkpoint, Immunology/Inflammation, Neuroscience, Apoptosis
Purity
0.9794
Bioactivity
Feladilimab (GSK3359609) is an IgG4 monoclonal antibody that is an ICOS agonist. Feladilimab binds to ICOS-expressing T cells, induces IFNγ, and increases PD-1/L1 expression. Feladilimab has anti-tumor activity and can be used to study cancer.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6326865-01 0.2 mL
NSF, CT (NSF, Vesicle-fusing ATPase, N-ethylmaleimide-sensitive fusion protein, Vesicular-fusion protein NSF) (APC)
Sign In for Pricing
View Details MBS6326865-02 5x 0.2 mL
NSF, CT (NSF, Vesicle-fusing ATPase, N-ethylmaleimide-sensitive fusion protein, Vesicular-fusion protein NSF) (APC)
Sign In for Pricing
View Details 
MBS1395714-01 0.02 mg (E-Coli)
Recombinant Geobacter sulfurreducens GTPase obg (obg)
Sign In for Pricing
View Details MBS1395714-02 0.02 mg (Yeast)
Recombinant Geobacter sulfurreducens GTPase obg (obg)
Sign In for Pricing
View Details MBS1395714-03 0.1 mg (E-Coli)
Recombinant Geobacter sulfurreducens GTPase obg (obg)
Sign In for Pricing
View Details